Dynamic Mechanistic Dominance in Fentanyl and Polysubstance Overdose: Implications for Next-Generation Reversal

Journal of Pharmacology and Experimental Therapeutics · Published 2026-08-01 · DOI 10.1016/j.jpet.2026.105002

Authors (3)

Michael Voronkov, George Milevich, John Abernethy

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Voronkov, M., Milevich, G., Abernethy, J. (2026). Dynamic Mechanistic Dominance in Fentanyl and Polysubstance Overdose: Implications for Next-Generation Reversal. Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/j.jpet.2026.105002

Related articles

• Interaction With the Lipid Membrane Influences Fentanyl Pharmacology · Advances in Drug and Alcohol Research · 2022 · Cites or is cited by this article
• DSP-2342, a novel 5-hydroxytryptamine 2A/7 receptor antagonist, has therapeutic potential for behavioral and psychological symptoms of dementia · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Structure-based prediction of muscarinic M1/M3 receptor antagonist activity: Curated dataset and scaffold-aware evaluation · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Improving drug delivery to mitigate cisplatin nephrotoxicity · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Striatal remodeling in Parkinson disease · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Preclinical pharmacology of N-pyrrolidino “nitazene” opioids appearing in nonmedical drug markets · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Modulation of morphine tolerance and dependence by pyrroloquinoline quinone in mice: Insights into mechanistic bridge from N-methyl-D-aspartate receptors-calcium/calmodulin-dependent protein kinase II signaling to oxidative neuroinflammation · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Comparative analysis of ligand binding affinities and functional profiles at recombinant human β-adrenergic receptor subtypes 1, 2, and 3 · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• An antidote in arms: A monoclonal antibody intervention to reverse fentanyl-induced respiratory apnea · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal
• Chemotype-Dependent Dissociation of Binding Affinity and Functional Potency in Synthetic Cannabinoids · Journal of Pharmacology and Experimental Therapeutics · 2026 · Same journal